Total Credits: 1 including 1 AOA Category 2-A Credit
Patrick J. Shenot, MD will discuss:
Focus on Overactive Bladder: A Fine-Tuned Approach to Attain Outcome Targets
The Initial Patient Evaluation and Screening
Treatment Selection to Optimize Efficacy and Tolerability
Dr. Shenot has no actual or potential conflict of interest in relation to this program or presentation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Florida Osteopathic Medical Association (FOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
GRIEVANCE POLICY: The FOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to FOMA Executive Director Steve Winn, by calling the FOMA Office at 850-878-7364 or by mail to FOMA, 2544 Blairstone Pines Drive, Tallahassee, FL 32301, or by email to email@example.com
|Focus on Overactive Bladder: A Fine-Tuned Approach to Attain Outcome Targets (1.3 MB)||Available after Purchase|
Patrick J. Shenot, MD is Professor of Urology, Residency Program Director and Deputy Chair, Department of Urology at Jefferson Medical College of Thomas Jefferson University. His major clinical interests are in neurology, voiding dysfunction, female urology, and urologic care of spinal cord injured patients. Dr. Shenot is a member of the American Urological Association, American College of Surgeons, American Spinal Cord Injury Association, American Paraplegia Society, International Continence Society and the Society for Female Urology and Urodynamics. Dr. Shenot is a principal investigator on many ongoing clinical trials involving genitourinary disorders. He has written numerous book chapters and peer-reviewed publications. His research focuses on the treatment of lower urinary tract dysfunction particularly bladder augmentation and both electrical and pharmacologic neuromodulation. He has been recognized in Castle Connolly's “America’s Top Doctors” Best Doctors in America® the Consumers' Research Council of America “Guide to America’s Top Surgeons” as well as Philadelphia Magazine's "Top Doctors" list of awards for excellence in research from the American Spinal Injury Association.